UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Controversy goes on over cause of high school boy’s death
by Shim Hyun-tai
2020-03-20 19:42
[Up-and-coming medical startups of 2020] CES 2020 award-winning startup Exosystems unveils ‘exoRehab’
by Shim Hyun-tai
2020-03-20 18:09
New COVID-19 cases fall back to 100 as quarantine tightened at airports
by Shim Hyun-tai
2020-03-20 14:22
Peptron’s trial of Parkinson’s disease treatment in full swing
by Shim Hyun-tai
2020-03-20 11:31
Novo Nordisk's Saxenda remains world’s top obesity treatment
by Shim Hyun-tai
2020-03-19 17:59
라인
Korea’s evolving virus tests -- from drive-through to walk-through
by Shim Hyun-tai
2020-03-19 17:17
Korea’s new virus cases rebound due to sporadic cluster outbreaks
by Shim Hyun-tai
2020-03-19 12:53
Drive-through screening of COVID-19 – advantages and limitations
by Shim Hyun-tai
2020-03-18 18:12
Despite falling new cases, cluster infections continue in Korea
by Shim Hyun-tai
2020-03-18 14:52
Alteogen ends p-1 clinical trial of breast cancer treatment
by Shim Hyun-tai
2020-03-17 18:16
라인
Korean researchers found substance inhibiting COVID-19
by Shim Hyun-tai
2020-03-17 18:08
Korea sees fewer than 100 new cases for 3rd day
by Shim Hyun-tai
2020-03-17 14:25
Who are most vulnerable to new coronavirus?
by Shim Hyun-tai
2020-03-16 18:55
[Report from Itaewon] Unmasked youngsters cavalier to COVID-19 in Itaewon
by Shim Hyun-tai
2020-03-16 18:28
New COVID-19 cases remain below 100 for 2nd day
by Shim Hyun-tai
2020-03-16 12:57
라인
Korea’s new COVID-19 cases remain at 100-range for 3 days
by Shim Hyun-tai
2020-03-14 15:51
Sanofi releases hemophilia B treatment Alprolix in Korea
by Shim Hyun-tai
2020-03-13 17:35
Korea’s COVID-19 cases near 8,000; recovered patients exceed new ones
by Shim Hyun-tai
2020-03-13 14:31
EDGC goes all out for global supply of COVID-19 test kit
by Shim Hyun-tai
2020-03-12 17:14
RIGHT Fund enlarges support for R&D on infectious diseases
by Shim Hyun-tai
2020-03-12 17:04
-
이전
11
12
13
14
15
16
17
18
19
20
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top